PDB Short entry for 3D25
HEADER    IMMUNE SYSTEM                           07-MAY-08   3D25              
TITLE     CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO   
TITLE    2 HUMAN CLASS I MHC HLA-A2                                             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN;   
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: MHC CLASS I ANTIGEN A*2;                                    
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 MOL_ID: 2;                                                           
COMPND   7 MOLECULE: BETA-2-MICROGLOBULIN;                                      
COMPND   8 CHAIN: B;                                                            
COMPND   9 FRAGMENT: UNP RESIDUES 22-119;                                       
COMPND  10 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3;                           
COMPND  11 ENGINEERED: YES;                                                     
COMPND  12 MOL_ID: 3;                                                           
COMPND  13 MOLECULE: NONAMERIC PEPTIDE FROM HA-1;                               
COMPND  14 CHAIN: C;                                                            
COMPND  15 FRAGMENT: UNP RESIDUES 137-145;                                      
COMPND  16 SYNONYM: MINOR HISTOCOMPATIBILITY ANTIGEN HA-1, MHAG HA-1;           
COMPND  17 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: HLA-A, HLAA;                                                   
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS;                            
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PGMT7;                                    
SOURCE  11 MOL_ID: 2;                                                           
SOURCE  12 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  13 ORGANISM_COMMON: HUMAN;                                              
SOURCE  14 ORGANISM_TAXID: 9606;                                                
SOURCE  15 GENE: B2M, CDABP0092, HDCMA22P;                                      
SOURCE  16 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE  17 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE  18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS;                            
SOURCE  19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  20 EXPRESSION_SYSTEM_PLASMID: PGMT7;                                    
SOURCE  21 MOL_ID: 3;                                                           
SOURCE  22 SYNTHETIC: YES;                                                      
SOURCE  23 OTHER_DETAILS: THE PEPTIDE IS COMMERCIALLY SYNTHESIZED. IT IS FOUND  
SOURCE  24 NATURALLY IN HUMANS.                                                 
KEYWDS    MHC, HLA-A2, SECONDARY ANCHOR RESIDUE, GLYCOPROTEIN, IMMUNE SYSTEM,   
KEYWDS   2 MINOR HISTOCOMPATIBILITY ANTIGEN, STEM CELL TRANSPLANTATION, IMMUNE  
KEYWDS   3 RESPONSE                                                             
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    S.NICHOLLS,K.P.PIPER,F.MOHAMMED,T.R.DAFFORN,S.TENZER,M.SALIM,         
AUTHOR   2 P.MAHENDRA,C.CRADDOCK,P.VAN ENDERT,H.SCHILD,M.COBBOLD,V.H.ENGELHARD, 
AUTHOR   3 P.A.H.MOSS,B.E.WILLCOX                                               
REVDAT   3   30-AUG-23 3D25    1       REMARK                                   
REVDAT   2   24-MAR-09 3D25    1       JRNL                                     
REVDAT   1   10-FEB-09 3D25    0                                                
JRNL        AUTH   S.NICHOLLS,K.P.PIPER,F.MOHAMMED,T.R.DAFFORN,S.TENZER,        
JRNL        AUTH 2 M.SALIM,P.MAHENDRA,C.CRADDOCK,P.VAN ENDERT,H.SCHILD,         
JRNL        AUTH 3 M.COBBOLD,V.H.ENGELHARD,P.A.MOSS,B.E.WILLCOX                 
JRNL        TITL   SECONDARY ANCHOR POLYMORPHISM IN THE HA-1 MINOR              
JRNL        TITL 2 HISTOCOMPATIBILITY ANTIGEN CRITICALLY AFFECTS MHC STABILITY  
JRNL        TITL 3 AND TCR RECOGNITION                                          
JRNL        REF    PROC.NATL.ACAD.SCI.USA        V. 106  3889 2009              
JRNL        REFN                   ISSN 0027-8424                               
JRNL        PMID   19234124                                                     
JRNL        DOI    10.1073/PNAS.0900411106                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.30 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELX                                                
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 20.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 94.9                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : NULL                   
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.169                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.204                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 0.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 5421                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 108030                 
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : NULL                   
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.156                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.191                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 0.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 74777                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 3130                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 0                                             
REMARK   3   SOLVENT ATOMS      : 354                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : NULL                    
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : NULL                    
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL                    
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 31647                   
REMARK   3   NUMBER OF RESTRAINTS                     : 39129                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.012                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.029                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.027                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.051                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.073                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.019                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.004                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.051                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.072                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228        
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 3D25 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-08.                  
REMARK 100 THE DEPOSITION ID IS D_1000047496.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 11-NOV-05                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 7.50                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : ID14-4                             
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.979355                           
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : ADSC                               
REMARK 200  DETECTOR MANUFACTURER          : NULL                               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : MOSFLM                             
REMARK 200  DATA SCALING SOFTWARE          : SCALA                              
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 108069                             
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.300                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 42.033                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.5                               
REMARK 200  DATA REDUNDANCY                : 4.000                              
REMARK 200  R MERGE                    (I) : 0.06400                            
REMARK 200  R SYM                      (I) : 0.06400                            
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 7.8000                             
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.37                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY IN SHELL       : 4.00                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.58300                            
REMARK 200  R SYM FOR SHELL            (I) : 0.58300                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 1.300                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: CNS                                                   
REMARK 200 STARTING MODEL: PDB ENTRY 1BD2                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 51.27                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 10K, 0.1 M HEPES, PH 7.5,       
REMARK 280  VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, PH 7.50            
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       40.49000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC                          
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC                   
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 3960 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 19180 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C                               
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 480                                                                      
REMARK 480 ZERO OCCUPANCY ATOM                                                  
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO                  
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS                
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;              
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):         
REMARK 480   M RES C SSEQI ATOMS                                                
REMARK 480     GLU A   89   CD   OE1  OE2                                       
REMARK 480     ARG A  108   CG   CD   NE   CZ   NH1  NH2                        
REMARK 480     LYS A  121   CD   CE   NZ                                        
REMARK 480     LYS A  146   CD   CE   NZ                                        
REMARK 480     LYS A  176   CD   CE   NZ                                        
REMARK 480     HIS A  192   CG   ND1  CD2  CE1  NE2                             
REMARK 480     HIS A  197   CG   ND1  CD2  CE1  NE2                             
REMARK 480     GLU A  222   CD   OE1  OE2                                       
REMARK 480     GLN A  255   CB   CG   CD   OE1  NE2                             
REMARK 480     LYS A  268   CB   CG   CD   CE   NZ                              
REMARK 480     LYS B   48   CG   CD   CE   NZ                                   
REMARK 480     GLU B   74   CB   CG   CD   OE1  OE2                             
REMARK 480     LYS B   75   CG   CD   CE   NZ                                   
REMARK 480     GLN B   89   CB   CG   CD   OE1  NE2                             
REMARK 480     LYS B   91   CE   NZ                                             
REMARK 480     LYS B   94   CD   CE   NZ                                        
REMARK 480     ARG B   97   CB   CG   CD   NE   CZ   NH1  NH2                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS                                      
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)               
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION                     
REMARK 500    SER B  88   CB    SER B  88   OG     -0.136                       
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  29     -127.04     49.28                                   
REMARK 500    PHE A  33       -6.92   -151.85                                   
REMARK 500    TYR A 123      -71.77   -111.64                                   
REMARK 500    SER A 195     -144.81   -135.49                                   
REMARK 500    SER A 207       42.56     70.85                                   
REMARK 500    TYR A 209      125.15   -170.76                                   
REMARK 500    ILE A 213      145.83    177.96                                   
REMARK 500    ASN B  17      114.33    -32.50                                   
REMARK 500    LYS B  48       55.45   -100.45                                   
REMARK 500    TRP B  60       -4.31     88.39                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 TYR A   27     VAL A   28                  147.96                    
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
DBREF  3D25 A    1   274  UNP    P01892   1A02_HUMAN      25    298             
DBREF  3D25 B    2    99  UNP    P61769   B2MG_HUMAN      22    119             
DBREF  3D25 C    1     9  UNP    Q6P189   HMHA1_HUMAN    137    145             
SEQRES   1 A  274  GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER          
SEQRES   2 A  274  ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY          
SEQRES   3 A  274  TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP          
SEQRES   4 A  274  ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE          
SEQRES   5 A  274  GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG          
SEQRES   6 A  274  LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU          
SEQRES   7 A  274  GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY          
SEQRES   8 A  274  SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY          
SEQRES   9 A  274  SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA          
SEQRES  10 A  274  TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU          
SEQRES  11 A  274  ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR          
SEQRES  12 A  274  LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU          
SEQRES  13 A  274  ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG          
SEQRES  14 A  274  ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR          
SEQRES  15 A  274  ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER          
SEQRES  16 A  274  ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE          
SEQRES  17 A  274  TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY          
SEQRES  18 A  274  GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG          
SEQRES  19 A  274  PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL          
SEQRES  20 A  274  VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS          
SEQRES  21 A  274  VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG          
SEQRES  22 A  274  TRP                                                          
SEQRES   1 B   98  GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS PRO          
SEQRES   2 B   98  ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR VAL          
SEQRES   3 B   98  SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU LEU          
SEQRES   4 B   98  LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER ASP          
SEQRES   5 B   98  LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU TYR          
SEQRES   6 B   98  TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR ALA          
SEQRES   7 B   98  CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS ILE          
SEQRES   8 B   98  VAL LYS TRP ASP ARG ASP MET                                  
SEQRES   1 C    9  VAL LEU HIS ASP ASP LEU LEU GLU ALA                          
FORMUL   4  HOH   *354(H2 O)                                                    
HELIX    1   1 ALA A   49  GLU A   55  5                                   7    
HELIX    2   2 GLY A   56  TYR A   85  1                                  30    
HELIX    3   3 ASP A  137  ALA A  150  1                                  14    
HELIX    4   4 HIS A  151  GLY A  162  1                                  12    
HELIX    5   5 GLY A  162  GLY A  175  1                                  14    
HELIX    6   6 GLY A  175  GLN A  180  1                                   6    
HELIX    7   7 GLN A  253  GLN A  255  5                                   3    
SHEET    1   A 8 GLU A  46  PRO A  47  0                                        
SHEET    2   A 8 THR A  31  ASP A  37 -1  N  ARG A  35   O  GLU A  46           
SHEET    3   A 8 ARG A  21  VAL A  28 -1  N  ALA A  24   O  PHE A  36           
SHEET    4   A 8 HIS A   3  VAL A  12 -1  N  PHE A   8   O  VAL A  25           
SHEET    5   A 8 THR A  94  VAL A 103 -1  O  ARG A  97   N  PHE A   9           
SHEET    6   A 8 PHE A 109  TYR A 118 -1  O  ARG A 111   N  ASP A 102           
SHEET    7   A 8 LYS A 121  LEU A 126 -1  O  TYR A 123   N  TYR A 116           
SHEET    8   A 8 TRP A 133  ALA A 135 -1  O  THR A 134   N  ALA A 125           
SHEET    1   B 4 LYS A 186  ALA A 193  0                                        
SHEET    2   B 4 GLU A 198  PHE A 208 -1  O  TRP A 204   N  HIS A 188           
SHEET    3   B 4 PHE A 241  PRO A 250 -1  O  ALA A 245   N  CYS A 203           
SHEET    4   B 4 THR A 228  LEU A 230 -1  N  GLU A 229   O  ALA A 246           
SHEET    1   C 4 LYS A 186  ALA A 193  0                                        
SHEET    2   C 4 GLU A 198  PHE A 208 -1  O  TRP A 204   N  HIS A 188           
SHEET    3   C 4 PHE A 241  PRO A 250 -1  O  ALA A 245   N  CYS A 203           
SHEET    4   C 4 ARG A 234  PRO A 235 -1  N  ARG A 234   O  GLN A 242           
SHEET    1   D 4 GLU A 222  GLN A 224  0                                        
SHEET    2   D 4 THR A 214  ARG A 219 -1  N  ARG A 219   O  GLU A 222           
SHEET    3   D 4 TYR A 257  GLN A 262 -1  O  HIS A 260   N  THR A 216           
SHEET    4   D 4 LEU A 270  LEU A 272 -1  O  LEU A 272   N  CYS A 259           
SHEET    1   E 4 LYS B   6  SER B  11  0                                        
SHEET    2   E 4 ASN B  21  PHE B  30 -1  O  ASN B  24   N  TYR B  10           
SHEET    3   E 4 PHE B  62  PHE B  70 -1  O  THR B  68   N  LEU B  23           
SHEET    4   E 4 GLU B  50  HIS B  51 -1  N  GLU B  50   O  TYR B  67           
SHEET    1   F 4 LYS B   6  SER B  11  0                                        
SHEET    2   F 4 ASN B  21  PHE B  30 -1  O  ASN B  24   N  TYR B  10           
SHEET    3   F 4 PHE B  62  PHE B  70 -1  O  THR B  68   N  LEU B  23           
SHEET    4   F 4 SER B  55  PHE B  56 -1  N  SER B  55   O  TYR B  63           
SHEET    1   G 4 GLU B  44  ARG B  45  0                                        
SHEET    2   G 4 GLU B  36  LYS B  41 -1  N  LYS B  41   O  GLU B  44           
SHEET    3   G 4 TYR B  78  ASN B  83 -1  O  ALA B  79   N  LEU B  40           
SHEET    4   G 4 LYS B  91  LYS B  94 -1  O  VAL B  93   N  CYS B  80           
SSBOND   1 CYS A  101    CYS A  164                          1555   1555  2.15  
SSBOND   2 CYS A  203    CYS A  259                          1555   1555  2.08  
SSBOND   3 CYS B   25    CYS B   80                          1555   1555  2.02  
CISPEP   1 TYR A  209    PRO A  210          0        25.71                     
CISPEP   2 HIS B   31    PRO B   32          0         2.93                     
CRYST1   53.170   80.980   56.260  90.00 112.32  90.00 P 1 21 1      2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.018808  0.000000  0.007721        0.00000                         
SCALE2      0.000000  0.012349  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.019214        0.00000